血清尿酸水平升高与接受体外受精或卵胞浆内单精子注射胚胎移植周期的多囊卵巢综合征女性不良生殖结局相关:一项回顾性队列研究
该回顾性队列研究纳入883例首次新鲜胚胎移植的多囊卵巢综合征女性,分析血清尿酸水平四分位与生殖结局的关系。结果显示,从最低四分位(Q1)到最高四分位(Q4),活产率呈显著下降趋势(Q1 61.8% vs Q4 45.9%,P趋势=.002),低出生体重百分比呈上升趋势(Q1 22.3% vs Q4 31.7%,P趋势=.049)。与Q1相比,Q4女性活产和临床妊娠概率显著降低,低出生体重风险显著升高(均P<.05)。
要点
- 血清尿酸水平从Q1到Q4,活产率呈显著下降趋势(Q1 61.8% vs Q4 45.9%,P趋势=.002)。
- 血清尿酸水平从Q1到Q4,低出生体重百分比呈上升趋势(Q1 22.3% vs Q4 31.7%,P趋势=.049)。
- 与Q1相比,Q4女性活产和临床妊娠概率显著降低,低出生体重风险显著升高(均P<.05)。
核心结论
- 血清尿酸水平升高与多囊卵巢综合征女性活产和临床妊娠概率降低及低出生体重风险升高相关。
- 这些关联可能受其他因素混杂,未来需要更多设计良好的研究来证实这些发现。
研究设计与样本
- 回顾性队列研究,在大学附属生殖医学中心进行。
- 初步纳入2010年1月至2021年1月期间接受首次体外受精或卵胞浆内单精子注射胚胎移植周期的1903例多囊卵巢综合征女性。
- 排除后,最终纳入883例首次新鲜胚胎移植周期的多囊卵巢综合征女性。
- 按血清尿酸水平四分位分析生殖结局趋势,采用 logistic 回归分析计算比值比,并使用广义相加模型可视化非线性关系。
- 主要结局为活产率。
主要发现
- 血清尿酸水平四分位间活产率呈显著下降趋势:Q1为61.8%,Q4为45.9%(P趋势=.002)。
- 低出生体重百分比从Q1的22.3%上升至Q4的31.7%(P趋势=.049)。
- 与Q1相比,Q4女性活产概率显著降低、临床妊娠概率显著降低、低出生体重风险显著升高(均P<.05)。
- 未调整和 adjusted 广义相加模型均显示,随着血清尿酸水平升高,临床妊娠概率和活产率总体呈下降趋势,低出生体重风险呈上升趋势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 这些关联可能受其他因素混杂。
- 未来需要更多设计良好的研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum uric acid levels are elevated in polycystic ovary syndrome, however, the relationship between serum uric acid level and reproductive outcomes in women with polycystic ovary syndrome remains unclear. OBJECTIVE: This study aimed to investigate the association between serum uric acid level and the reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles. STUDY DESIGN: This was a retrospective cohort study performed at a university-affiliated reproductive medicine center. A total of 1903 women with polycystic ovary syndrome undergoing their first in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles between January 2010 and January 2021 were initially included. The trends for reproductive outcomes in polycystic ovary syndrome across quartiles of serum uric acid levels were assessed. A logistic regression analysis was performed to obtain the odds ratios for in vitro fertilization outcomes based on the quartiles of serum uric acid with or without adjusting for potential confounding variables. Using generalized additive models, serum uric acid was further treated as its original continuous property to visualize its nonlinear relationship with in vitro fertilization outcomes. The live birth rate was the main outcome. RESULTS: After exclusions, a total of 883 women with polycystic ovary syndrome with their first fresh-embryo transfer cycles were included. In quartiles of serum uric acid levels, there was a significant decreasing trend in the live birth rate from the lowest quartile (Q1: 61.8%) to the highest (Q4: 45.9%) (Ptrend=.002). The percentage of low birthweight increased from Q1 (22.3%) to Q4 (31.7%) (Ptrend=.049). Compared with those in Q1, women in Q4 showed a significant lower probability of live birth and clinical pregnancy and a higher risk for low birthweight (all P<.05). Both the unadjusted and adjusted generalized additive models indicated that as the serum uric acid level increased, the probability of clinical pregnancy and the live birth rate exhibited an overall decreasing profile, and the risk for low birthweight showed an increasing profile. CONCLUSION: An elevated serum uric acid level is associated with decreased probabilities of live birth and clinical pregnancy and an increased risk for low birthweight in women with polycystic ovary syndrome. However, these associations may be confounded by other factors and more well-designed studies are needed to confirm these findings in the future.
引用
- Yang H, Wang G, Liu C, et al. Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study. Am J Obstet Gynecol. 2022. PMID: 36403859. doi:10.1016/j.ajog.2022.11.1287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。